Lifeward Ltd. (NASDAQ:LFWD) Short Interest Update

Lifeward Ltd. (NASDAQ:LFWD) was the target of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 2,351,929 shares, an increase of 18.8% from the January 29th total of 1,979,952 shares. Based on an average daily volume of 241,976 shares, the days-to-cover ratio is presently 9.7 days. Currently, 13.1% of the company’s stock are short sold. Currently, 13.1% of the company’s stock are short sold. Based on an average daily volume of 241,976 shares, the days-to-cover ratio is presently 9.7 days.

Hedge Funds Weigh In On Lifeward

Several hedge funds have recently modified their holdings of the company. HRT Financial LP boosted its stake in shares of Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after buying an additional 29,423 shares during the last quarter. Virtu Financial LLC lifted its holdings in Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares during the period. Jane Street Group LLC lifted its holdings in Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after acquiring an additional 29,927 shares during the period. Finally, Citadel Advisors LLC boosted its position in Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares during the last quarter. Institutional investors own 26.76% of the company’s stock.

Lifeward Price Performance

Shares of NASDAQ LFWD traded up $0.09 during trading on Thursday, hitting $6.08. The stock had a trading volume of 4,828 shares, compared to its average volume of 31,002. The firm has a fifty day moving average of $7.08 and a two-hundred day moving average of $7.47. The company has a market capitalization of $9.26 million, a PE ratio of -0.17 and a beta of 0.12. Lifeward has a 12 month low of $4.14 and a 12 month high of $35.40.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. HC Wainwright decreased their target price on shares of Lifeward from $156.00 to $54.00 and set a “buy” rating for the company in a research report on Tuesday, November 18th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Lifeward currently has a consensus rating of “Hold” and a consensus price target of $51.00.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.